Andrey Skripkin

An intellectual disability syndrome with single-nucleotide variants in O-GlcNAc transferase

Abstract Intellectual disability (ID) is a neurodevelopmental condition that affects ~1% of the world population. In total 5−10% of ID cases are due to variants in genes located on the X chromosome. Recently, variants in OGT have been shown to co-segregate with X-linked intellectual disability (XLID) in multiple families. OGT encodes O-GlcNAc transferase (OGT), an essential enzyme that catalyses […]

An intellectual disability syndrome with single-nucleotide variants in O-GlcNAc transferase Read More »

N-acetylglucosamine inhibits inflammation and neurodegeneration markers

Background: In the demyelinating disease multiple sclerosis (MS), chronic-active brain inflammation, remyelination failure and neurodegeneration remain major issues despite immunotherapy. While B cell depletion and blockade/sequestration of T and B cells potently reduces episodic relapses, they act peripherally to allow persistence of chronic-active brain inflammation and progressive neurological dysfunction. N-acetyglucosamine (GlcNAc) is a triple modulator of

N-acetylglucosamine inhibits inflammation and neurodegeneration markers Read More »